Tue. 14 May 2024, 4:13pm ET
Benzinga
Earnings, Earnings Beats, News
Taysha Gene Therapies (NASDAQ:TSHA) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 64.29 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $3.41 million which beat the analyst consensus estimate of $2.56 million by 33.24 percent. This is a 27.52 percent decrease over sales of $4.71 million the same period last year.